About this trial
The primary objective of this case-control study aims to explore the role of bacterium Ruminococcus gnavus (R. gnavus) with intestinal biopsy and faecal sampling in the initiation and the development of spondyloarthritis (SPA) in comparison with health control subjets (patients without chronic disease but have indication to digestive endoscopy).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients ⩾ 18 years;
Diagnosed as spondyloarthritis (SpA) according ASAS classification;
Affiliated to a social security scheme;
Have signed the written informed consent form.
Disqualifiers
Subjects unable to understand the proposed study and/or sign a informed consent form;
Pregnant women or breast feeding women;
Subjects under guardianship or curatorship;
Have taken antibiotic 1 month prior to inclusion;
Trial design
Parallel
Treatments tested in this trial
Biopsy
Procedure/SurgeryBiopsy during recto-coloscopy
Treatment groups
Trial outcomes
Primary outcomes
Isolation and characterization of R. gnavus
Isolation and characterization of R. gnavus bacterium from intestinal biopsy.
Bacteria analysis
Analysis of repartition of R. gnavus bacterium in each group and the comparison between 2 groups.
Secondary outcomes
Bacterial strain's abundance
Compare the abundance by RT-q-PCR of bacterial strain (R. gnavus) between mucus biopsy sampling and faecal sampling, collected from PCR patients or control subjects respectively.
Mucin-degradation of Ruminococcus gnavus
Study the ability of the strain to grow on mucins of intestinal biopsy, colored after fixation to carnoy.
RNA sequencing analysis of biopsy
RNA sequencing analysis of rectal biopsy between SPA patients and control subjects.
Interaction between bacteria and intestinal epithelial cells
In order to study the interaction between bacteria and intestinal epithelial cells in culture (organoids). Study the induction of several target genes as peptides anti-microbians, mucin or chemokines by RT-q-PCR.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.